Get the app
US › Healthcare

Tiziana Life Sciences Ltd (TLSA)

US · Healthcare · Biotechnology

$0.69+11.03%
Last close · 2026-11-06

Key statistics

Market cap
$115.1M
Forward P/E
0.0
P/B
2,569.66
Book value
$-0.02
EPS (TTM)
$-0.21
52-week high
$1.95
52-week low
$0.76
50-day MA
$1.01
200-day MA
$1.22
Beta
0.44

Analyst view

Analysts rate Tiziana Life Sciences Ltd a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $8.10.

Shareholding

Insiders
47.36%
Institutions
2.02%

Largest institutional holders

FundStake
Dauntless Investment Group, LLC0.91%
Mid-American Wealth Advisory Group, Inc.0.25%
Zhang Financial LLC0.10%
The Goldman Sachs Group Inc0.09%
Citadel Advisors Llc0.06%
The Colony Group LLC0.06%
Geode Capital Management, LLC0.06%
UBS Group AG0.06%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tiziana Life Sciences Ltd — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.